68 related articles for article (PubMed ID: 31215527)
21. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
22. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome.
Wang K; Li Y
Front Endocrinol (Lausanne); 2023; 14():1191759. PubMed ID: 37929034
[TBL] [Abstract][Full Text] [Related]
23. Expression of PCOS candidate genes in bovine fetal and adult ovarian somatic cells.
Liu M; Bastian NA; Hartanti MD; Hummitzsch K; Irving-Rodgers HF; Anderson RA; Rodgers RJ
Reprod Fertil; 2022 Nov; 3(4):273-86. PubMed ID: 36346793
[TBL] [Abstract][Full Text] [Related]
24. A review on the role of miRNA-324 in various diseases.
Kadkhoda S; Hussen BM; Eslami S; Ghafouri-Fard S
Front Genet; 2022; 13():950162. PubMed ID: 36035118
[TBL] [Abstract][Full Text] [Related]
25. MiR-130a-3p blocks Wnt signaling cascade in the triple-negative breast cancer by targeting the key players at multiple points.
Poodineh J; Sirati-Sabet M; Rajabibazl M; Mohammadi-Yeganeh S
Heliyon; 2020 Nov; 6(11):e05434. PubMed ID: 33225091
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-Mediated Gene Regulatory Mechanisms in Mammalian Female Reproductive Health.
Gebremedhn S; Ali A; Hossain M; Hoelker M; Salilew-Wondim D; Anthony RV; Tesfaye D
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477832
[TBL] [Abstract][Full Text] [Related]
27. microRNA biomarkers in cystic diseases.
Woo YM; Park JH
BMB Rep; 2013 Jul; 46(7):338-45. PubMed ID: 23884099
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of Ovarian Granulosa Cells in Polycystic Ovarian Syndrome Is Regulated by MicroRNA-24 by Targeting Wingless-Type Family Member 2B (WNT2B).
Yuanyuan Z; Zeqin W; Xiaojie S; Liping L; Yun X; Jieqiong Z
Med Sci Monit; 2019 Jun; 25():4553-4559. PubMed ID: 31215527
[TBL] [Abstract][Full Text] [Related]
29. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.
Jiang YC; Ma JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3286-3293. PubMed ID: 29917177
[TBL] [Abstract][Full Text] [Related]
30. microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.
Wu YX; Lin YS; Li SC; Yao X; Cheng M; Zhu L; Liu HY
Reprod Biol Endocrinol; 2021 Nov; 19(1):170. PubMed ID: 34814928
[TBL] [Abstract][Full Text] [Related]
31. Circ_0043532 regulates miR-182/SGK3 axis to promote granulosa cell progression in polycystic ovary syndrome.
Xu L; Xiong F; Bai Y; Xiao J; Zhang Y; Chen J; Li Q
Reprod Biol Endocrinol; 2021 Nov; 19(1):167. PubMed ID: 34740363
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.
Zhong Z; Li F; Li Y; Qin S; Wen C; Fu Y; Xiao Q
Mol Med Rep; 2018 Apr; 17(4):4889-4898. PubMed ID: 29363717
[TBL] [Abstract][Full Text] [Related]
33. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4.
Bao D; Li M; Zhou D; Zhuang C; Ge Z; Wei Q; Zhang L
J Steroid Biochem Mol Biol; 2021 May; 209():105844. PubMed ID: 33582305
[TBL] [Abstract][Full Text] [Related]
34. Current Management of Polycystic Ovary Syndrome: From Bench to Bedside.
Laganà AS; Vitale SG; Noventa M; Vitagliano A
Int J Endocrinol; 2018; 2018():7234543. PubMed ID: 30538744
[No Abstract] [Full Text] [Related]
35. Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials.
Laganà AS; Vitagliano A; Noventa M; Ambrosini G; D'Anna R
Arch Gynecol Obstet; 2018 Oct; 298(4):675-684. PubMed ID: 30078122
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
